A phase 1 trial combines immunotherapy and an oncolytic virus for high-grade neuroendocrine tumors, aiming to enroll 36 patients by 2030. The trial evaluates Opdivo, Yervoy, and Seneca Valley ...

The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors. With the recent approval by the U.S. Food and Drug Administration (FDA) of ...

such as C 11-5HTP or Ga 68-DOTA octreotate, will improve staging and follow-up of therapy in patients with neuroendocrine tumors. Somatostatin analogs (e.g., octreotide, lanreotide) will continue ...

A recent study in JAMA Internal Medicine reveals that CT scans, while vital for diagnosis, may elevate cancer risk due to radiation exposure. With CT scan usage up 30% since 2007, experts estimate ...

CT scans, also known as CAT scans, have become a mainstay in modern medicine, used to detect tumors and diagnose a wide range of illnesses. Since 2007, the number of annual CT exams in the US has ...

A new UK study by the Institute of Cancer Research (ICR) in London has made a startling discovery: computed tomography (CT) scans, a ubiquitous medical imaging device available in hospitals and ...

Getty A new study has found that the radiation from CT scans could eventually lead to over 100,000 future cancer diagnoses. On Monday, April 14, JAMA Internal Medicine — a monthly peer-reviewed ...

The scan was the largest underwater 3D scan ever made, amounting to 16 terabytes of data, according to a new article from National Geographic. NatGeo, in tandem with Atlantic Productions ...

Rodin Eckenroth/WireImage Teddi Mellencamp revealed that doctors have given her a 50% chance of surviving cancer — but says she remains hopeful due to a key factor. The Real Housewives of ...

The approval for use in advanced neuroendocrine tumors is supported by data from the phase 3 CABINET trial (ClinicalTrials.gov Identifier: NCT03375320). The double-blind, placebo-controlled study ...